An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)

This study has been terminated.
(The overall profile does not support development for obesity)
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: February 1, 2007
Last updated: February 12, 2015
Last verified: February 2015